The popularity of GLP1-s is hitting a fever-pitch, with many touting that it’s a miracle weight loss drug, despite its eye-popping price tag. The high demand is creating a pressure point on health plans and employer pharmacy teams, making the expensive drug accessible to their members but not bankrupting the whole plan. According to a recent report from GoodRx, Americans spent more than $200 million on weight loss medications in 2024 alone.